The goal of the Tulane Center of Excellence in Sex-Based Precision Medicine (CESPM), founded in 2021, is to address fundamental issues of differences between males and females in health and disease, and to rapidly translate sex-related research findings into novel strategies for the diagnosis, prevention and treatment of multiple conditions in Louisiana.

The Tulane Center of Excellence in Sex-Based Precision Medicine (CESPM) seeks to advance knowledge on how biological sex modifies biology, health, disease, and medicine.

Everything we know about the diagnosis and treatment of disease originates from studies conducted on male cells, male animal models, and men. Historically, medical science has assumed that male and female cells were biologically identical, and evidence-based medicine was defined by clinical trials performed predominantly in men. While scientists and clinicians have observed differences between males and females in diseases for years, and the United States (US) National Institutes of Health (NIH) mandated the inclusion of women in NIH-funded clinical trials, as well as the consideration of sex as a biological variable (SABV) in NIH-funded basic research, the scientific community has not yet fully addressed the issue. The TCESBM seeks to rectify this.